|
Home : Unsafe Drugs : Avandia : News Articles : Glitazones' MI risks compared | Endocrinology Update Glitazones' MI risks compared | Endocrinology Update
The suspected increase in cardiovascular events with rosiglitazone (Avandia) compared with pioglitazone (Actos) has been confirmed in a large meta-analysis. In a pooled analysis of more than 810000 real-world type 2 ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




